Medicinal Chemistry, Rega Institute for Medical Research, KU Leuven, Herestraat 49 Box 1041, B-3000 Leuven, Belgium.
Laboratory for Biocrystallography, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Herestraat 49 Box 822, B-3000 Leuven, Belgium.
Eur J Med Chem. 2018 Mar 25;148:384-396. doi: 10.1016/j.ejmech.2018.02.013. Epub 2018 Feb 14.
Aminoacyl-tRNA synthetases (aaRSs) are enzymes that precisely attach an amino acid to its cognate tRNA. This process, which is essential for protein translation, is considered a viable target for the development of novel antimicrobial agents, provided species selective inhibitors can be identified. Aminoacyl-sulfamoyl adenosines (aaSAs) are potent orthologue specific aaRS inhibitors that demonstrate nanomolar affinities in vitro but have limited uptake. Following up on our previous work on substitution of the base moiety, we evaluated the effect of the N-position of the adenine by synthesizing the corresponding 3-deazaadenosine analogues (aaS3DAs). A typical organism has 20 different aaRS, which can be split into two distinct structural classes. We therefore coupled six different amino acids, equally targeting the two enzyme classes, via the sulfamate bridge to 3-deazaadenosine. Upon evaluation of the inhibitory potency of the obtained analogues, a clear class bias was noticed, with loss of activity for the aaS3DA analogues targeting class II enzymes when compared to the equivalent aaSA. Evaluation of the available crystallographic structures point to the presence of a conserved water molecule which could have importance for base recognition within class II enzymes, a property that can be explored in future drug design efforts.
氨酰-tRNA 合成酶(aaRSs)是将氨基酸精确连接到其对应的 tRNA 上的酶。这个过程对于蛋白质翻译至关重要,被认为是开发新型抗菌药物的可行靶点,只要能够识别出具有物种选择性的抑制剂。氨酰磺酰胺腺苷酸(aaSAs)是强效的同源特异性 aaRS 抑制剂,在体外具有纳摩尔亲和力,但摄取有限。在我们之前关于碱基部分取代的工作基础上,我们通过合成相应的 3-脱氮腺苷类似物(aaS3DAs)来评估腺嘌呤 N 位的影响。一个典型的生物体有 20 种不同的 aaRS,可以分为两个不同的结构类别。因此,我们通过磺酰胺桥将六种不同的氨基酸连接到 3-脱氮腺苷上,这些氨基酸均匀地靶向两类酶。在评估所得到的类似物的抑制效力时,注意到明显的类别偏见,与等效的 aaSA 相比,针对 II 类酶的 aaS3DA 类似物的活性丧失。对现有晶体结构的评估指出存在一个保守的水分子,这对于 II 类酶中的碱基识别可能很重要,这一特性可以在未来的药物设计工作中进行探索。